PUBLISHED FOR OPPOSITION
on 12 Nov 2024
Last Applicant/ Owned by
714 8th Avenue South
Nashville
TN
37203
Serial Number
98363044 filed on 18th Jan 2024
Registration Number
N/A
Correspondent Address
Katherine Todd
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
CONCERT
Providing an interactive website featuring technology that allows users in the field of genetic testing to analyze market and pricing statistics, to verify genetic testing categorization and coding, and to categorize areas of molecular pathology for the purpose of identifying areas for economic growth and policy development; software as a service (SAAS) services featuring software that allows user Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Bioinformatics health care services, namely, providing an online computer database in the field of genetic testing information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; medical information services, namely, reporting of genetic testing results directly to clients; providing a web site featuring information regarding genetics for medical purposes; providing an on-line computer database in the field of genetics information for medical purposes; providing an online computer database of patient medical information and medical test information designed to facilitate sharing of patient medical information and medical test information amongst clinicians within departments and clinics
First Use Date in General
01st Mar 2017
First Use Date in Commerce
01st Mar 2017
Class [042]
Computer & Software Services & Scientific Services
Providing an interactive website featuring technology that allows users in the field of genetic testing to analyze market and pricing statistics, to verify genetic testing categorization and coding, and to categorize areas of molecular pathology for the purpose of identifying areas for economic growth and policy development; software as a service (SAAS) services featuring software that allows users in the field of genetic testing to analyze market and pricing statistics, to verify genetic testing categorization and coding, and to categorize areas of molecular pathology for the purpose of forecasting areas of economic growth and policy development; application service provider (ASP) services featuring software for accessing genotyping databases and data management, data storage, data analysis and report generation, all in the fields of genetics and genetics testing; bioinformatics scientific research services, namely, providing a computer database in the field of genetic testing information and featuring inputting and collection of data and information all for scientific purposes; providing an interactive website featuring technology that allows users to access a proprietary genetic testing database of genetic tests; providing an interactive website featuring technology that allows users to order tests from reference laboratories and to receive results electronically; providing temporary use of online non-downloadable computer software for providing and publishing genetic testing information, including price, methodology, sample requirements, and turn-around time estimates; providing temporary use of online non-downloadable cloud computing software for access to healthcare medical testing databases and for use in data management, data storage, data analysis, and report generation; providing an interactive website featuring technology that allows users to create an esoteric testing formulary, manage vendor relationships, create test-specific rules, manage disease algorithms, and create detailed reports based on this information; providing website featuring information in the field of clinical research and scientific research of genetics; providing an online computer database in the field of genetics information for scientific research and clinical research purposes; providing an interactive website featuring technology that allows users of an online marketplace for healthcare providers the ability to place orders for genetic testing
First Use Date in General
01st Mar 2017
First Use Date in Commerce
01st Mar 2017
Class [036]
Insurance & Financial Services
Providing an online computer database for financial transaction and payment processing services in the field of cost and payment management of genetic testing
First Use Date in General
01st Mar 2017
First Use Date in Commerce
01st Mar 2017
Class [035]
Advertising, Business & Retail Services
Business information analytics and management consulting services in the field of genetic testing; business services, namely, providing an online computer database in the field of business information about business cost and payment management of genetic testing; business services, namely, providing an online computer database in the field of cost and payment management of genetic testing; business data analytical services, namely, collecting and analyzing genetic testing cost data for insurance providers; business data analytical services, namely, collecting and analyzing genetic testing cost data for healthcare providers; outsource service provider in the field of the business analytics of genetic testing
First Use Date in General
01st Mar 2017
First Use Date in Commerce
01st Mar 2017
Mark Details
Serial Number
No 98363044
Mark Type
No Service Mark
Attorney Docket Number
No 118891.0800
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 12th Nov 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 12th Nov 2024 | PUBLISHED FOR OPPOSITION |
| 23rd Oct 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 02th Oct 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 01st Oct 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 01st Oct 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 01st Oct 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 14th Aug 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 14th Aug 2024 | NON-FINAL ACTION E-MAILED |
| 14th Aug 2024 | NON-FINAL ACTION WRITTEN |